Your browser doesn't support javascript.
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
"Pontali, Emanuele.
Non-conventional | WHO COVID | ID: covidwho-348590
ABSTRACT
Cytokine release syndrome plays a crucial pathogenic role in COVID-19 pneumonia. This pilot study provides the first evidence of the safety of anti-IL-1 treatment with highdose IV anakinra in 5 patients, who experienced a positive outcome.
Search on Google
Print
XML
Collection: Databases of international organizations Database: WHO COVID Type of study: Prognostic study Document Type: Non-conventional

Similar

MEDLINE
LILACS
LIS
Search on Google
Print
XML
Collection: Databases of international organizations Database: WHO COVID Type of study: Prognostic study Document Type: Non-conventional